•
2017 Leading Edge Urology: 49th DUKE UROLOGIC ASSEMBLY & UROLOGIC CANCER SYMPOSIUM
Registration Form • March 9–12, 2017 • Orlando, Florida 2017 Leading Edge Urology: 49th DUKE UROLOGICASSEMBLY & UROLOGIC CANCER SYMPOSIUM
A g e n d A • M A R C H 9 – 1 2 , 2 0 1 7
MedICAL dIReCTORS daniel J. george, Md Michael n. Ferrandino, Md Professor of Medicine Associate Professor of Surgery Professor in Surgery Director, Minimally Invasive Urologic Surgery Duke Cancer Institute Duke Department of Surgery, Division of Urology
2017 VICTOR A. POLITAnO, Md, LeCTuReSHIP SPeAKeR david F. Penson, Md, MPH Chair, Department of Urologic Surgery Hamilton and Howd Professor of Urologic Oncology Director, Center for Surgical Quality and Outcomes Research Co-Leader, Cancer Health Outcomes and Control Research Program Vanderbilt University Medical Center
gueST FACuLTY SPeAKeRS dipen J. Parekh, Md edna Maldonado, CPC, ACS-uR Dr. Victor Politano Chair in Urology ICD 10 CM Trainer Professor of Surgery Coding Coordinator at AUA Director of Robotic Surgery Baltimore, Maryland University of Miami Miller School of Medicine
duKe unIVeRSITY FACuLTY Rajan T. Gupta, MD Associate Professor of Radiology Director, Abdominal Imaging Fellowship Program Duke Department of Radiology
Jiaoti Huang, MD, PhD Professor and Chairman Department of Pathology
Brant A. Inman, MD, MS Cary N. Robertson, MD, Associate Professor of Surgery Duke Department of Surgery Division of Urology
Aaron C. Lentz, MD Associate Professor of Surgery Duke Department of Surgery Division of Urology
Bridget F. Koontz, MD Associate Professor Duke Department Radiation Oncology Duke Cancer Center
Judd W. Moul, MD James H. Semans, MD, Professor of Surgery Director, Duke Prostate Center Duke Department of Surgery Division of Urology
Steven R. Patierno, PhD Deputy Director, Duke Cancer Institute Director, Cancer Control & Population Sciences Professor of Medicine; Pharmacology and Cancer Biology; and Community and Family Medicine Duke Department of Medicine, Division of Oncology
Andrew C. Peterson, MDProfessor of SurgeryDirector, Reconstructive Urology & Genitourinary Cancer Survivorship FellowshipDuke Department of SurgeryDivision of Urology
Glenn M. Preminger, MDJames F. Glenn, MD, Professor of UrologyChief, Division of UrologyDirector, Endourology, Metabolic Stone Disease, Laparoscopic & Robotic Surgery Fellowship Professor of SurgeryDuke Department of Surgery Division of Urology
Cary N. Robertson, MDAssociate Professor of SurgeryDuke Department of Surgery Division of Urology
Jonathan C. Routh, MD, MPHAssociate Professor of SurgeryAssociate Professor in PediatricsDuke Department of Surgery Division of Urology
Tian Zhang, MDInstructor in the Department of MedicineDuke Department of MedicineDivision of Oncology
Thursday, March 9, 2017 • Educational Sessions are in SEGURA 3 &4 10:00 am REGISTRATION and EXHIBITS Session I MINIMALLY INVASIVE MANAGEMENT OF BLADDER CANCER 12:15 pm WELCOME12:30 pm Endoscopic Management of Upper Tract Urothelial Carcinoma - Ferrandino 1:00 pm Robotic Cystectomy: Current Role in 2017 - Parekh 1:30 pm Role of Hyperthermia in Bladder Cancer - Inman 2:00 pm Bladder Sparing Radiotherapy- Koontz 2:30 pm Tumor Board/Case Discussions: Superficial TCC; Upper Tract TCC 3:00 pm BREAK and EXHIBITS (DEL LAGO 3 & 4)Session II RADIOTHERAPY, CHEMOTHERAPY & IMAGINING IN PROSTATE CANCER 3:15 pm Novel Radiotherapy Approaches for Prostate Cancer - Koontz 3:45 pm Prostate MRI – What the Urologist Needs to Know - Gupta 4:15 pm Image Guided Prostate Cancer Therapy: Research, Development and Future Trends - Robertson 4:45 pm Long Term Effects of Radiation in the Cancer Patient - Peterson 5:15 pm Evolving Role of Chemotherapy for Hormone-sensitive prostate cancer - Zhang 5:45 pm Tumor Board/Case Discussions: Locally Advanced PCa; Low Risk PCa 6:15 pm SESSION ADJOURNMENT 6:30 pm WELCOME RECEPTION
Friday, March 10, 2017 • Educational Sessions are in SEGURA 3 & 4 6:30 am REGISTRATION, BREAKFAST and EXHIBITS (DEL LAGO 3 & 4)Session III MULTIDISCIPLINARY MANAGEMENT OF ADVANCED PROSTATE CANCER 7:00 am Surgical Management of High Risk Prostate Cancer - Moul 7:30 am Role of Metastastectomy for Advanced Prostate Cancer - Inman 8:00 am Integrating Non-hormonal Therapies into Advanced Prostate Cancer Care - George 8:30 am Moonshot for Cancer: Local and National Policy Implications - Patierno 9:00 am Tumor Board/Case Discussions: Oligometastatic PCa, Bone dominant PCaT 9:30 am BREAK and EXHIBITS (DEL TLAGO 3 & 4)Session IV PATHOLOGY/GENETICS/IMMUNOTHERAPIES FOR UROLOGIC ONCOLOGY 9:45 am Integrating Immunotherapy into Management of Advanced Bladder Cancer - Zhang10:15 am Interpreting Evidence Based Research - Routh 10:45 am The Role of Pathology and Pathologists in Precision Medicine of Prostate Cancer - Huang 11:15 am VICTOR A. POLITANO, MD LECTURESHIP: presented by Penson PSA Screening: Science, Politics and Uncertainty
12:00 pm VICTOR A. POLITANO, MD, Non-CME LUNCHEON and EXHIBITS 1:00 pm Prostate Cancer Genomics: What, When, and Which? - Moul 1:30 pm Tumor Board/Case Discussions: BRCA-2 Mutated PCa, Neuroendocrine PCa 2:00 pm SESSION ADJOURNMENT
Saturday, March 11, 2017 • Educational Sessions are in SEGURA 3 & 4 6:30 am REGISTRATION, BREAKFAST, and EXHIBITS (DEL LAGO 3 & 4)Session V RENAL CELL CARCINOMA MANAGEMENT 7:00 am Review of Modifiers (value and new) Used in Urology Billing - Maldonado 7:30 am Current Techniques and Findings in Renal Imaging - Gupta 8:00 am Integrating Novel Agents into the Management of Metastatic RCC - George 8:30 am Warming Up to Renal Ischemia during Partial Nephrectomy - Parekh 9:00 am Genetic Variants of RCC: Diagnosis and Management - Robertson 9:30 am Tumor Board/Case Discussions: Multifocal RCC, Intermediate risk metastatic RCC10:00 am BREAK and EXHIBITS (DEL LAGO 3 & 4)Session VI RECONSTRUCTIVE UROLOGY 10:15 am Review CPT Coding Changes Affecting Urologists - Maldonado10:45 am Hematuria from Guidelines to Blue Lights - Penson 11:15 am Management of Gender Identity Dysphoria - Routh11:45 pm Artificial Urinary Sphincter - Peterson12:15 pm Penile Implant - Lentz12:45 pm Case Discussions 1:15 pm SESSION ADJOURNMENT
Sunday, March 12, 2017 • Educational Sessions are in SEGURA 3 & 4 6:30 am BREAKFAST, and EXHIBITS (DEL LAGO 3 & 4)Session VII ENDOUROLOGY 7:00 am An Update on ICD-10 and ICD-10-CM Coding Exercises - Maldonado 7:30 am Medical Stone Management: Perspectives from the AUA Nephrolithiasis Guidelines Panel - Preminger 8:00 am Urinary Stone Imaging - Ferrandino 8:30 am Recalcitrant Bladder Neck Contracture - Lentz 9:00 am Antibiotic Use During Endourologic Surgery - Preminger 9:30 am Case Discussions10:00 am CONFERENCE ADJOURNMENT
Opportunities for Q&A will be provided at the conclusion of each presentation
JW Marriott orlando Grande lakes • 4040 Central Florida Parkway • Orlando, FL 32837 • 800-266-9432
2017 Duke Urologic Assembly ACCOMOdATIOn InFORMATIOn
Gather with friends, family members and colleagues at the Duke Urologic Assembly being held at the JW Marriott Orlando Grande Lakes. A serene oasis from the hustle and bustle of cen-tral Florida’s theme parks, JW Marriott, offers a luxuri-ous and relaxing resort experience for family as well as business travelers. Play a challenging round of golf
on the beautiful 18-hole course, or indulge in a mas-sage or facial at the award-winning three-story spa. From surrey bike rentals, fishing, kayak eco-tours and guided nature hikes to a daily activities program and a fun-filled pool complex that’s rated among the best in Orlando, recreational options for families are truly impressive. If you are looking for a magical adventure, the re-sort offers shuttle service to Walt Disney World®, Sea-World® and Universal Orlando®, so you can explore the area without the worry of rental cars and parking fees.
We have secured a limited block of rooms with a group rate of $249 plus tax and $30 daily resort fee. The confirmed room rates will be available three days pre/post based on group room availability. Make your reservations NOW on our reservation site! Or Call 1.800.266.9432. The Cut-Off Date for accepting reser-vations into this discounted room block is Wednesday, February 8, 2017 or until the room block is full. After the block is full or the cut-off date, reservations will be subject to availability at then current rates.
LEADING EDGE UROLOGY
49th DUKE UROLOGIC ASSEMBLY & UROLOGIC CANCER SYMPOSIUM
presented by
Duke Urologic SurgeryDuke Cancer Institute
March 9–12, 2017JW Marriott Orlando Grande Lakes
4040 Central Florida Parkway • Orlando, FL 32837 • 800-266-9432
2017 COURSE OVERVIEW Join an outstanding roster of national urolo-gists, oncologists, radiologists, and coding ex-perts participating in a comprehensive scientific program that encompasses leading edge up-dates on the most effective and efficient diag-nosis and treatments in the sub-specialties of urology.
Healthcare professionals attending this sympo-sium will be engaged through interactive talks, supplemented with video surgical presenta-tions, interactive case presentations, and panel discussions on the latest evidence-based clinical approaches to managing a wide range of uro-logic conditions.
NEEDS ASSESSMENT There continues to be significant educational need for this annual meeting and scientific program. The rapid evolution of knowledge coupled with an unprecedented release of practice changing clinical trials require an on-going review to ensure accurate diagnosis and management options by all levels of the uro-logic community.
The process to assess an educational need for this course was drawn from recent thera-peutic guidelines, published sources of clinical data, and available research on knowledge and practice gaps among health care professionals working in this area.
CONFERENCE WEBSITE https://surgery.duke.edu/DUA2017Check the website for the most detailed, up-to-date conference information.
EDUCATIONAL OBJECTIVESAt the conclusion of this activity, participants should be able to:• Apply Evidence Based Medicine (EBM) in the urologic practice to better diagnose, triage, and manage patients in various stages of urologic diseases• Develop collaboration between urologists, genitourinary oncologists, and radiation oncologists for patient care from diagnosis to management• Review common coding questions, update CPT coding skills, ICD-10 coding, and modifiers in billing to optimize reimbursement • Integrate new and modified testing and optimal medical treatment selection for prevention of stone disease and optimal outcomes• Devise treatment algorithms and coordinate multi-specialty care for patients presenting with gender identity issues• Assess the evolving knowledge regarding the biology of genitourinary cancer coupled with the release of practice changing clinical trials and approvals that help define outcomes and treatment choices for patients
TARGET AUDIENCEAddressing current issues and technologies for the diagnoses and treatments in the subspecial-ties of urology and urologic oncology, this edu-cational conference will meet the continuing educational needs, enhance knowledge, skills and improve patient care by Urologists, Oncol-ogists, Physician Assistants, Nurse Practitioners, Nurses, Residents and other allied health medi-cal staff locally, regionally and nationally.LE
AD
ING
EDG
EU
RO
LOG
Y49
th D
UK
E U
ROLO
GIC
ASS
EMBL
Y&
URO
LOG
IC C
AN
CER
SY
MPO
SIU
M
Mar
ch 9
–12,
201
7
CO
NFE
REN
CE
WEB
SITE
htt
ps:
//su
rger
y.d
uke
.ed
u/D
UA
2017
LEADING EDGE UROLOGY 49th DUKE UROLOGIC ASSEMBLY &UROLOGIC CANCER SYMPOSIUM
March 9 – 12, 2017
JW Marriott Orlando Grande Lakes
JW Marriott orlando Grande lakes4040 Central Florida ParkwayOrlando, FL 32837
800-266-9432
CONFERENCE REGISTRATION CATEGORIES AND FEESAdvanced registration is required prior to course start date of March 9, 2017. Seating is limited register early! On or Before After February 6 February 6PHYSICIAN $ 600 $ 650PA, NP, RN $ 375 $ 425RESIDENTS/LEARNERS $ 200 $ 200
Conference Registration Fee Includes: •EntrancetoallScientificSessions •ProgramMaterials •Breakfasts&Breaks •OneWelcomeReceptionticket •OneLuncheonticket
Spouse/Guest Registration Fee $75.00 Includes: •OneWelcomeReceptionticket •OneLuncheonticket
ONLINE REGISTRATION website: http://events.duke.edu/dua2017
REGISTRATION FORMS with credit card payments may also be faxed to Duke University Conference Services at 919-660-1769.
CANCELLATION POLICYRegistration refund request must be submitted in writing no later than February 6, 2017. All re-fund requests will be subject to a $100 process-ing fee. No refunds will be made after February 6, 2017.
SPECIAL NEEDSDuke Surgery is committed to making its ac-tivities accessible to all individuals. If you are in need of special assistance, please call 919-668-3532 or submit your request in writing to [email protected].
QUESTIONSFor questions or sponsorship, please contact: 919-668-3532 [email protected]
R e g I S T R AT I O n I n F O
Duk
e U
nive
rsity
Sch
ool o
f M
edic
ine
DU
MC
370
7 •
Du
rham
, NC
277
1039
1-83
22
This activity has been planned and imple-mented by the Duke University Health System Department of Clinical Education and Pro-fessional Development, the Duke Division of Urologic Surgery, and the Duke Cancer Insti-tute for the advancement of patient care. The Duke University Health System Department of Clinical Education and Professional Develop-ment is accredited by the American Nurses Credentialing Center (ANCC), the Accredita-tion Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME) to provide con-tinuing education for the health care team.
In support of improving patient care, the Duke University Health System Department of Clinical Education and Professional Devel-opment is accredited by the American Nurses Credentialing Center (ANCC), the Accredita-tion Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (AC-CME), to provide con-tinuing education for the health care team.
CRedIT deSIgnATIOnCategory 1: Duke University Health System Department of Clinical Education and Profes-sional Development designates this live activ-ity for a maximum of 20.25 AMA PRA Cat-egory 1 Credit(s)TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Nurse CE: Duke University Health System Department of Clinical Education and Profes-sional Development designates this activity for up to 20.25 credit hours for nurses. Nurses should claim only credit commensurate with the extent of their participation in this activity.
REGISTER NOW! http://events.duke.edu/dua2017